Add to a list

Inactive Instrument

Ergomed plc Stock OTC Markets

ERGM.F

GB00BN7ZCY67

Biotechnology & Medical Research

OTC Markets Traded

Analysts' recommendations: Ergomed plc

23-09-04	Analyst recommendations: Ergomed, Dollar general, Salesforce, Citigroup, Goldman Sachs...
22-11-17	FTSE 100 Closed Down 0.1% as U.K.'s New Fiscal -2-	DJ
22-11-17	Large UK Fiscal Tightening Could Reduce Need for -2-	DJ
22-08-04	Berenberg Starts Ergomed Coverage With Buy Rating	MT

More recommendations

News in other languages: Ergomed plc

23-09-06	Mandarine Europe Microcap " Un fonds vraiment Pan-Européen de Microcaps "
23-09-04	MIDDAY BRIEFING - Unternehmen und Märkte -2-
22-08-04	Bolsa de Madrid: La tecnología está cansada de ir cuesta abajo
22-08-04	Avis d'analystes du jour : HSBC, JCDecaux, Elior, Equasens, DiaSorin, TeamViewer, Just Eat, Interroll...
22-08-04	La "Tech" en a marre de baisser

More news

Managers and Directors: Ergomed plc

Manager	Title	Age	Since
Zubair Javeed CEO	Chief Executive Officer	54	2026-04-06
Nancy Maher CTO	Chief Tech/Sci/R&D Officer	-	2024-08-31
Sladana Sturlic CTO	Chief Tech/Sci/R&D Officer	-	1999-08-31

Director	Title	Age	Since
Zubair Javeed BRD	Director/Board Member	54	2025-12-18

More insiders

Ergomed PLC is a United Kingdom-based company that is primarily focused on providing specialized services to the biopharmaceutical industry. The Company operates through two segments: Clinical Research Services (CRO) and Pharmacovigilance (PV). Its CRO segment is the process of developing medical therapies, drugs and knowledge for safe use in healthcare. Its PV segment is engaged in the activities relating to the detection, understanding and prevention of adverse effects or other drug-related problems throughout its lifecycle. The Company serves over 100 countries. It operates in North America, United Kingdom and Europe, Middle East and Africa, and Asia. The Companies subsidiaries include PrimeVigilance Inc., PrimeVigilance USA Inc., PrimeVigilance s.r.o., PharmInvent regulatory s.r.o., PrimeVigilance Japan K.K., Haemostatix Limited and Sound Opinion Limited.

Employees

1,500

Sector

Biotechnology & Medical Research

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

05-10	Ergomed Group Limited Announces Termination of Miroslav Reljanovic as Director Appointment, Effective April 29, 2026	CI
05-10	Ergomed Group Limited Appoints Alaric Richard Warwick Jackson as Director, Effective May 8, 2026	CI
12-22	Ergomed Group Limited Appoints Zubair Javeed as Director, Effective December 19, 2025	CI
24-10-04	Ergomed Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-10-01	CEL-SCI Corporation Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine in Head and Neck Cancer	CI
23-11-14	Ergomed Delists From London Stock Exchange	MT
23-11-12	Permira Advisers Ltd. completed the acquisition of Ergomed plc from Amati Global Investors Ltd. and others.	CI
23-11-09	Milton plans energy focus; Guild completes fund raise	AN
23-11-09	UK Court Clears Permira's Ergomed Purchase	MT
23-10-27	Ergomed says conditions satisfied for Permira takeover	AN
23-10-27	Permira's Takeover of Ergomed Nears Completion	MT
23-10-23	Ergomed's Takeover by Permira Advisers Expected to Take Effect mid-November	MT
23-10-13	Ergomed Shareholders Back Eden AcquisitionCo's Bid	MT

23-11-14	Ergomed strongly positioned for future growth in new partnership with Permira	GL
23-11-10	Samson Rock Capital LLP - Form 8.3 - Ergomed Plc	PR
23-10-27	Samson Rock Capital LLP - Form 8.3 - Ergomed Plc	PR
23-10-26	Samson Rock Capital LLP - Form 8.3 - Ergomed Plc	PR
23-10-25	Samson Rock Capital LLP - Form 8.3 - Ergomed Plc	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ERGOMED PLC	-.--%	-.--%	-	-	886M
WUXI APPTEC CO., LTD.	+3.13%	+13.95%	+64.21%	+94.35%	57.82B
ARGENX SE	-0.80%	-6.55%	+53.21%	+70.16%	53.71B
INSMED INCORPORATED	-0.27%	-5.77%	+6.75%	+433.06%	23.8B
BIONTECH SE	+1.76%	-1.65%	-16.86%	-15.01%	23.26B
WUXI BIOLOGICS (CAYMAN) INC.	-0.56%	+6.10%	+44.56%	-3.75%	20.7B
GENMAB A/S	-1.25%	-2.85%	+33.31%	-30.19%	17.81B
PHARMAESSENTIA CORPORATION	+10.00%	-4.30%	+208.33%	+370.99%	16.9B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-2.61%	+10.00%	+47.02%	+699.54%	16.36B
EXELIXIS, INC.	-0.39%	-1.00%	+26.08%	+186.49%	13.96B
Average	+0.90%	+1.42%	+51.84%	+200.63%	27.15B
Weighted average by Cap.	+1.06%	+1.35%	+51.20%	+159.14%

Ergomed plc Stock OTC Markets

Stocks

ERGM.F

GB00BN7ZCY67

Biotechnology & Medical Research

Latest news : Ergomed plc

Analysts' recommendations: Ergomed plc

Press Releases: Ergomed plc

News in other languages: Ergomed plc

Managers and Directors: Ergomed plc

Bio Therapeutic Drugs

Company Profile